mRNA lipid nanoparticle vaccines: current status, challenges and future prospects
mRNA vaccines have become a clinically validated vaccine platform, as demonstrated by the success of COVID-19 vaccines such as Comirnaty and Spikevax, owing to their rapid design, manufacturing scalability, and capacity to induce in situ antigen expression. A key factor underlying this success is the lipid nanoparticle...
Zhi-Neng Wu, Jinghu Lou, Yi Cheng et al.
· Molecular Biomedicine · 0 citations